Clinical Trial Update: Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children [Phase 2]

View source ↗

Summary

Clinical Trial Update describing the long-term immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African children in a Phase 2 study that is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Shigellosis

Drugs mentioned

• altSonflex1-2-3 Shigella Vaccine (Shigella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diarrhoea | Phase 2 | Status: NOT_YET_RECRUITING